Compounds > pyrazinamide
Page last updated: 2024-10-20

pyrazinamide and Maxillary Sinusitis

pyrazinamide has been researched along with Maxillary Sinusitis in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Maxillary Sinusitis: Inflammation of the NASAL MUCOSA in the MAXILLARY SINUS. In many cases, it is caused by an infection of the bacteria HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE; or STAPHYLOCOCCUS AUREUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouchentouf, R1
Bouaity, B1
Touati, M1
Benjelloun, A1
Ali Aitbenasser, M1

Other Studies

1 other study available for pyrazinamide and Maxillary Sinusitis

ArticleYear
[Primary sinonasal tuberculosis: apropos of a case].
    The Pan African medical journal, 2013, Volume: 14

    Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxil

2013